Millennium Development Goal Acceleration Initiative
1
Min de Salud Colombia
1
Minisisterio da Saude - Secretaria de Vigilância em Saúde Doença pelo Novo Coronavírus, Brasilia
1
Ministere de la Sante, Rwanda
1
Ministerio da Saude Brasilia, Centro Colaborador do SUS
1
Ministerio de Salud y Deportes Bolivia
1
Ministerio de Salud
1
Ministerio de Salud Chile
1
Ministerio de Salud de El Salvador
1
Ministerio de Salud Publica Paraguay
1
Ministerio de Salud Pública del Ecuador
1
Ministerio de Salud Pública y Bienestar Social (MSPBS), Paraguay
1
Ministerio de salud pública y bienestar social, Organización Panamericana de la Salud, et al.
1
Ministerio de Salud Pública y Bienestar Social. Programa Nacional de Control de VIH
1
Ministerio de Salud Pública, Paraguay
1
Ministerio de salud y deportes, Bolivia
1
Ministerio de Salud y Desarrollo Social. Argentina
1
Ministerio de Salud, Bogota, Colombia
1
Ministerio de sanidad - España
1
Ministerio der Salud Argentina
1
Ministero della Salute
1
Ministerul sănătăţii al republicii Moldova
1
Ministère de la Santè Maroc
1
Ministère de la Santé du Bénin
1
Ministère de la Santé, Burkina Faso
1
Ministry of Health & Family Welfare ,India
1
Ministry of Health & Family Welfare Government of India
1
Ministry of Health & Social Welfare India
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Social Services (MOHSS) & Ministry of Education, Arts and Culture (MOEAC)
1
Ministry of Health and Social Welfare, The United Republic of Tanzania
1
Ministry of Health and Social Welfare, Zimbabwe
1
Ministry of Health and Wellness
1
Ministry of Health Ethiopia
1
Ministry of Health, Ghana
1
Ministry of Health, Malawi
1
Ministry of Health, Nepal
1
Ministry of Health, Republic of Kenya
1
Ministry of Health, Republic of South Africa
1
Ministry of Health, South Africa
1
Ministry of Health, Uganda
1
Mjelde, Marit
1
Morbidity and Mortality Weekly Report
1
MSPP, Haiti
1
Mukhtar A Adeiza, Abdullah A Abba, Juliana U Okpapi
1
Mukund Uplekar, Diana Weil, Hannah Monica Dias et al.
1
Muñiz F. J., de Casado G. C. , et al.
1
N. G. Kiobi, S. N. Nebere, J. K. Karanja
1
N. Schoenfeld, W. Haas, E. Richter, et al.
1
N. Schönfeld, W. Haas, E. Richter et al.
1
N. Talat, S. Perry, J. Personnet, et al.
1
N. Tavagnutti
1
National CBRNE Medical and Advisory Centre Norway et al.
1
National Center for Emerging and Zoonotic Infectios Diseases
1
National Center for HIV
1
National Clinical Guideline Centre
1
National Department of Health, South Africa
1
National Institue of communicable Diseases, India
1
National Institute for Health and Care Excellence
1
National Institute for Health and Care Excellence (NICE)
1
National Library of Medicine
1
National Library of Medicine (NIH)
1
National Tuberculosis Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Bangladesh
1
National Tuberculosis, Leprosy and Lung Disease Program (NTLD-Program), Kenya
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nesheim, Ingrid
1
New Jersey Medical School
1
NHS
1
Nicole Ritz, Folke Brinkmann, Cornelia Feiterna-Sperling. et al.
1
Norsk institutt for vannforskning (NIVA)
1
Novel Psychoactive Treatment UK Network (NEPTUNE)
1
OCCHA Services
1
OCHA
1
Optimal Blood Use Project
1
Organisation mondiale de la Santé
1
Organisation Mondiale de la Santé (OMS)
1
Organisation Mondiale de la Santé (TB/HIV Working Group)
1
Organización Mundial de la Salud
1
Organización Panamerica de la Salud
1
Organización Panamericana de la Salud
1
Organizaición Mundial de la Salud Américas
1
Organizatión Mundial de la Salud
1
P. Brouwers
1
P. J. Dodd
1
P. Zitko, Á. Passi-Solar et al.
1
Palmero, D.
1
Pan American Health Organization (PAHO), OPS
1
Pan American Health Organization PAHO, World Health Organization WHO
1
Pazan, F.
1
Páez, L.S.
1
Peer J
1
Perez S.F., Pizon L.A.B., Polo C.L.P
1
Pfizer
1
Pharmaceuticals and Supply Agency
1
PLoS Neglected Tropical diseases
1
PLOS One
1
PLOS Phatogens
1
PMC
1
PNUD, et al.
1
President's Malaria Initiative et al.
1
Preussler, S.
1
Prof. C. Abobltins, L. Brown, Prof N. Curtis, et al.
1
Prof. Dr. A. K. Azad
1
Prof. Dr. rer. nat. Gerd Glaeske Dr. med. Rüdiger Holzbach
1
Prof. Dr. S. Tahamina
1
Prof. Q. T. Islam
1
Progama Nacional de Control de Zoonosis
1
PROVEA , Programa Venezolano de Educación - Acción en Derechos Humanos
1
Pub Med
1
Public Health England
1
Q.M. Trinh
1
R. Colebunders
1
R. D. Blacutt Paniagua
1
R. Diel, A. Nienhaus
1
R. Diel, B. Hauer, R. Loddenkemper, et al.
1
R. Humeniuk, S. Henry-Edwards, R. Ali
1
RACGP
1
Radiation Emergency Assistance Center
1
Radiation Emergency Assistance Center
1
Rector, N., D. Bourdeau, K. Kitchen, et al.
1
Reijer, P.
1
Republic of Kenya, Ministry of Health
1
República bolivariana de Venezuela, Juventud
1
Research Triangle Institute (RTI) International
1
République du Bénin Ministère de la Santé Direction de la Santé de la Mère et de l’Enfan
1
Robert Koch Instiut (RKI)
1
Rockville, Maryland, USA: ICF International
1
Roja-Palma, C.
1
Rosas, F.
1
S. Chakraborty, K. Syal, R. Bhattacharyya, et al.
1
S. Groth, G. Forte et al.
1
S. H.-L. Fry
1
S. Hung
1
S. L. Barnabas
1
S. Novoa, B. Nieto et al.
1
Sächsischen Staatsministeriums für Soziales und Verbraucherschutz und der Landesdirektion Sachsen zur Gesundheitsversorgung
1
Scientific Data
1
SCK-CEN
1
SEGO, SAC Ecuador
1
Semmes, Oliver John
1
Servizio Sanitario Regionale Emilia-Romagna
1
Sociedad Boliviana de Medicina Crítica y Terapia Intensiva
1
Sociedad Boliviana de Medicina Crítica y Terapia Intensiva/ Ministerio de Salud Bolivia
1
Sociedad Colombiana de Cardiología y cirugía cardiovascular
1
Springer
1
Stadt Münster
1
State Goverment Victoria
1
Stefan Mauss, et al.
1
Stop TB
1
STUK
1
Sv Madhu, S. Srivastava
1
Swe, Thida
1
System Socio Sanitario Regione Lombardia ATS Milano Città Metropolitana
1
T. Evans
1
T. Frieden
1
T. Schaberg, T. Bauer, F. Brinkmann, et al.
1
T. Taro
1
TB a!ert
1
TB Alliance
1
TB Care
1
TB/CTA
1
TDR
1
The Global Fund
1
The Republic of the Union of Myanmar, Ministry of Social Welfare, Relief and Resettlement, Relief and Resettlement Department
1
Trials
1
Tuberculosis Coalition for Technical Assistance (TBCTA), USAID
1
U.S. Department of Health & Human Services
1
U.S. Department of Health and Human Services
1
U.S. Department of Human Services
1
U.S. Food & Drug Administration
1
UNICEF
1
UNICEF Kosovo in cooperation with Kosovo Health Foundation
1
UNICEF, World Health Organisation (WHO)
1
Unidad de vigilancia de la Salud, Gobierno de la répubica de Honduras
1
UNION
1
Unión Internacional Contra la tuberculosis y Enfermedades Respirations
1
Unión Internacional Contra la Tuberculosis y Enfermedades Respiratorias
1
United Nations
1
United Nations ECLAC
1
United Nations Office on Drug and Crime UNODC
1
United Nations Office on Drugs and Crime
1
United Nations Office on Drugs and Crime UNODC
1
United Nations, The World Bank, European Union and African Development Bank
1
Universität Heidelberg
1
V. Nankabirwa , J. K. Tumwine, O. Namugga, et al.
1
V. Pathak, Z. Harrington, C. C. Dobler
1
V.N. Nguyen
1
van Straten, B.
1
Vanegas, D.
1
Velazquez Berumen, A.
1
Veláquez-Ortiz, N.
1
Verjeen, M.
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
W. S. Hinojosa Gallo
1
W.Cheung
1
Wagner, U. et al.
1
Wai-him Cheung, Anna Kit-sum Lam & Se-fong Hung
1
Wang, Wenjuan, Gheda Temsah, and Emily Carter
1
WHO Regional Office for South-East Asia
1
WHO Western Pacific, Manila, and WHO South-East Asia, New Delhi
1
WHO, INFOSAN, FAO
1
Wood MC, DePaolo, F, Whitaker RD
1
World Health Organization (WHO), Regional Office for South-East Asia
1
World Health Organization (Bangladesh)
1
World Health Organization (TB/HIV Working Group)
1
World Health Organization (WHO) and InterAgency Standing Committee (IASC)
1
World Health Organization (WHO), Regional Office for the Western Pacific
1
World Health Organization WHO and International Atomic Energy Agency IAEA
1
World Health Organization WHO and World Intellectual Property Organization
1
World Health Organization WHO Regional Office for South-East Asia
1
World Health Organization WHO, Regional Office for Europe
1
World Health Organization WHO, CDC, UNHCR
1
World Health Organization WHO, SAGE
1
World Health Organization, Europe
1
World Health Organization. Regional Office for South-East Asia
1
WTO, WHO, WIPO
1
Xiaoyan Ke & Jing Liu
1
Yotsu,R.R.
1
Васильева Ирина Анатольевна, Самойлова Анастасия Геннадьевна, Эргешов Атаджан Эргешович et al.
1
Всемирная организация здравоохранения
1
Всемирная организация здравоохранения (ВОЗ)
1
Департамент по ВИЧ/СПИД, Департамент «Остановить ТБ», Всемирная организация здравоохранения
1
федеральное государственное бюджетное учреждение центральный научно-исследовательский институт туберкулеза российской академии медицинских наук, Американский международный союз здравоохранения
Latin America and the Caribbean is characterized by a matrix of social inequality whose axes —such as
socioeconomic stratum, gender, stage in the life cycle, ethnicity and race, territory, disability, and immigration
status— create multiple, often concurrent, situations of exclusion and discri...mination. The coronavirus
disease (COVID-19) pandemic has exacerbated wide social gaps and it is no coincidence that Latin America
and the Caribbean is one of the regions in which the health and socioeconomic impacts of the pandemic have
been the most severe, which shows that the costs of inequality are unsustainablemore
Durante muchos años, la enfermedad de Chagas ha sido una entidad olvidada en nuestro medio, pese a que Colombia posee las condiciones apropiadas para que esta infección se desarrolle y se perpetúe en el tiempo.
Esto se refleja en el poco conocimiento de la enfermedad y en la existencia de muchos... individuos que sufren una pérdida significativa de su calidad y esperanza de vida, así como en costos importantes para el sistema de salud.more
La implementación de la presente Norma Nacional y Manual de Procedimientos Técnicos de la Leishmaniasis en el país, permitirá al personal de salud del sistema público y privado fortalecer sus capacidades técnicas y operativas a través de la estandarización y unificación de estrategias y acc...iones para mejorar la prevención, atención, control, vigilancia entomológica y epidemiológica de esta enfermedad de manera oportuna y eficiente. Así mismo promoverá el cumplimiento de la Gestión Participativa y de Atención en Salud a través de la participación e involucramiento de la sociedad civil en la adopción de conductas prevenibles y de atención oportuna, así como demandar mayor acceso a la salud a través de la abogacía ante las Autoridades Locales y Municipales para el fortalecimiento en la otorgación de recursos humanos, insumos, infraestructura y medicamentos para este fin.more
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-...19 policy advice to WHO member states and in particular the advice on how to reach the COVID-19 vaccination targets. more
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The 2022 edition of the report is as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2022, 202 countries and territories with more than 99% of the world’s population and TB cases reported datamore
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim...s to review the current knowledge of this disease and challenges ahead.more
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
This global progress report attempts to lay the groundwork for the kind of accelerated action needed. Section 1 presents key data, trends and developments in women’s, children’s and adolescents’ health and well-being. That is followed in Section 2 by a deeper dive into the impact of the COVID-...19 pandemic, which has created and contributed to many threats and challenges to progress for women, children and adolescents. In Section 3, the report concludes with recommendations for accelerating progress towards the achievement of the 2030 Agenda even in such challenging times, with an emphasis on partnership
and clear-eyed recognition of the consequences of failing to do better.more
La néphrologie pédiatrique (NP) a connu ces dernières années des progrès impressionnants en matière de soins. Cependant, le plus grand défi dans notre continent africain est de fournir aux enfants atteints de maladie rénale l’accès à une prise en
charge spécialisée par des néphrologu...es pédiatriques ayant une bonne formation, ainsi que la possibilité d’avoir un accès abordable aux techniques modernes, aux médicaments efficaces et à des stratégies de prévention. En Afrique, le développement de la NP a été très lent et sans collaboration réelle entre les pays concernés, ce qui a renforcé ma conviction sur la nécessité d’amener les néphrologues pédiatres africains à œuvrer ensemble, par le biais d’un ouvrage commun, à mettre en lumière les données spécifiques de notre continent dans ce domaine.more
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
and delivering more than $200 million worth of diagnostic equipmentmore
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the... near ubiquity of STEC worldwide, there is no single definitive solution for controlling STEC that will work alone or in all situations. Instead, the introduction of multiple interventions applied in sequence, as a “multiple-hurdle scheme” at several points throughout the food chain (including processing, transport and handling) will be most effective.
This report summarizes the review and evaluation of interventions applied for the control of STEC in cattle, raw beef and raw milk and raw milk cheese manufactured from cows’ milk, and also evaluates available evidence for other small ruminants, swine and other animals. The information is presented from primary production, to the end of processing, providing the reader with information on the currently available interventions based on the latest scientific evidence.
This work was undertaken to support the development of guidelines for the control of STEC in beef, raw milk and cheese produced from raw milk by the Codex Committee on Food Hygiene (CCFH).more
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...anisms underlying Trypanosoma cruzi’s infection and the host-parasite interactions that follow, prompt diagnosis and treatment remain a challenge, particu-larly in developing countries and also in those where the disease is considered non-endemic. This review intends to present an up-to-date review of the parasite’s life cycle, genetic diversity, virulence factors, and infective mechanisms, as well as the epidemiology, clinical presentation, diagnosis, and treatment options of the main chronic complications of Chagas disease.more
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...s disease, particularly the severe cardiac form, is available in the literature. However, information concerning events during the acute phase of the disease is scarce. In this review, we will discuss the current status of acute Chagas disease cases globally, the immunological findings related to the acute phase and their possible influence in disease outcome, and reactivation of Chagas disease in immunocompromised individuals, a key point for transplantation and HIV invection management.more
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...test practical guidance on use of newly recommended diagnostics as well as guidance in key technical areas, including quality assurance and quality management systems, specimen collection and registration, procurement and supply-chain management, diagnostic connectivity, biosafety, data management, human resources, strategic planning, and model algorithms. The key changes are:
inclusion of recent or updated WHO recommendations for tests to diagnose TB and detect drug resistance;
alignment with the latest WHO critical concentrations for phenotypic drug-susceptibility testing (DST) and the new definitions of pre-XDR-TB and XDR-TB;
updated information on building quality-assured TB testing and management capacity using the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) approach (Score-TB package1);
updated information on assessing, analysing and optimising TB diagnostic networks; and
updated information on the use of next-generation sequencing (NGS) to detect mutations associated with drug resistance for surveillance purposes.
The document also provides references to resources and tools relevant for work on laboratory strengthening.more
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...vudini et tenofoviri disoproxili fumarati compressi)
Tenofovir disoproxil fumarate tablets (tenofoviri disoproxili fumarati compressi)
ATC/DDD Classification
Temporary
Finalmore
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in... order to make evidence-based decisions on the most appropriate control measures for each specific situation. IVM can be used for surveillance and control or for elimination of VBDs and can help reduce the development of insecticide resistance through the rational use of these products. This document provides instructions for fulfillment of the 2008 PAHO mandate set forth in CD 48/13 (Integrated Vector Management).more
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...subnacional y local, a actualizar y tomar decisiones basadas en la evidencia sobre las medidas de control más apropiadas para cada situación específica. El MIV puede utilizarse cuando la meta es la vigilancia y el control o la eliminación (dependiendo de la situación específica) de las ETV y puede contribuir a reducir el desarrollo de la Resistencia a los insecticidas mediante el uso racional de estos productos. Este documento contiene las instrucciones para llevar a cabo el mandato de la OPS del 2008 sobre el control integrado de vectores (resolución CD48.R8, documento CD48/13) y, en particular, complementa una serie de guías de la OMS publicadas en el 2012more